|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent BlackRock Health Sciences Trust insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why BlackRock Health Sciences Trust insider buys are important for investors to follow.
Date | Insider | Price | Amount |
6-28-2019 Insider Buy |
Cynthia Egan Director |
$38.92
CAGR »
|
$145,444.04 3,737 shares |
9-19-2012 Insider Buy |
Michael J. Castellano Director |
$27.71
CAGR »
|
$11,083.96 400 shares |
Also See: Institutional Holders of BME
Also See: SEC filings
Below we present the annualized performance delivered by BlackRock Health Sciences Trust stock since 6-28-2019 (the date of the most recent
insider purchase). The performance of the investment from the time BlackRock Health Sciences Trust insider buying occurred is the ultimate
test of whether insiders were right about BME being a good buy.
Growth of $10,000.00
With Dividends Reinvested
|
Start date: |
07/01/2019 |
|
End date: |
05/01/2024 |
|
Start price/share: |
$38.98 |
|
End price/share: |
$39.48 |
|
Starting shares: |
256.54 |
|
Ending shares: |
340.11 |
|
Dividends reinvested/share: |
$12.00 |
|
Total return: |
34.27% |
|
Average Annual Total Return: |
6.28% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$13,427.09 |
|
Years: |
4.84 |
|
|
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
07/01/2019 |
|
End date: |
05/01/2024 |
|
Start price/share: |
$38.98 |
|
End price/share: |
$39.48 |
|
Dividends collected/share: |
$12.00 |
|
Total return: |
32.08% |
|
Average Annual Total Return: |
5.92% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$13,208.46 |
|
Years: |
4.84 |
|
BlackRock Health Sciences Trust Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent BlackRock Health Sciences Trust insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding BME
|
|